Your browser doesn't support javascript.
loading
Tackling antimicrobial resistance across sub-Saharan Africa: current challenges and implications for the future.
Godman, Brian; Egwuenu, Abiodun; Wesangula, Evelyn; Schellack, Natalie; Kalungia, Aubrey Chichonyi; Tiroyakgosi, Celda; Kgatlwane, Joyce; Mwita, Julius C; Patrick, Okwen; Niba, Loveline Lum; Amu, Adefolarin A; Oguntade, Racheal Tomilola; Alabi, Mobolaji Eniola; Ncube, Nondumiso B Q; Sefah, Israel Abebrese; Acolatse, Joseph; Incoom, Robert; Guantai, Anastasia Nkatha; Oluka, Margaret; Opanga, Sylvia; Chikowe, Ibrahim; Khuluza, Felix; Chiumia, Francis K; Jana, Collins Edward; Kalemeera, Francis; Hango, Ester; Fadare, Joseph; Ogunleye, Olayinka O; Ebruke, Bernard E; Meyer, Johanna C; Massele, Amos; Malande, Oliver Ombeva; Kibuule, Dan; Kapona, Otridah; Zaranyika, Trust; Bwakura-Dangarembizi, Mutsa; Kujinga, Tapiwanashe; Saleem, Zikria; Kurdi, Amanj; Shahwan, Moyad; Jairoun, Ammar Abdulrahman; Wale, Janney; Brink, Adrian J.
Afiliação
  • Godman B; Department of Pharmacoepidemiology, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.
  • Egwuenu A; Centre of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates.
  • Wesangula E; Department of Public Health Pharmacy and Management, Sefako Makgatho Health Sciences University, Pretoria, South Africa.
  • Schellack N; AMR Programme, Nigeria Centre for Disease Control, Jabi, Abuja, Nigeria.
  • Kalungia AC; Patient and Health Workers Safety Division, AMR Focal Point, Ministry of Health, Nairobi, Kenya.
  • Tiroyakgosi C; Department of Pharmacology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
  • Kgatlwane J; Department of Pharmacy, School of Health Sciences, University of Zambia, Lusaka, Zambia.
  • Mwita JC; Ministry of Health, Gaborone, Botswana.
  • Patrick O; Department of Pharmacy, University of Botswana, Gaborone, Botswana.
  • Niba LL; Department of Internal Medicine, Faculty of Medicine, University of Botswana, Gaborone, Botswana.
  • Amu AA; Effective Basic Services (eBASE) Africa, Bamenda, Cameroon, Africa.
  • Oguntade RT; Faculty of Health and Medical Sciences, Adelaide University, Adelaide, Australia.
  • Alabi ME; Effective Basic Services (eBASE) Africa, Bamenda, Cameroon, Africa.
  • Ncube NBQ; Department of Public Health, University of Bamenda, Bambili, Cameroon.
  • Sefah IA; Pharmacy Department, Eswatini Medical Christian University, Mbabane, Eswatini.
  • Acolatse J; Pharmacy Department, Eswatini Medical Christian University, Mbabane, Eswatini.
  • Incoom R; School of Pharmaceutical Sciences, College of Health Sciences, University of Kwazulu-natal (UKZN), Durban, South Africa.
  • Guantai AN; School of Public Health, University of the Western Cape, Cape Town, South Africa.
  • Oluka M; Department of Pharmacy Practice, School of Pharmacy, University of Health and Allied Sciences, Volta Region, Ghana.
  • Opanga S; Pharmacy Directorate, Cape Coast Teaching Hospital (CCTH), Cape Coast, Ghana.
  • Chikowe I; Pharmacy Directorate, Cape Coast Teaching Hospital (CCTH), Cape Coast, Ghana.
  • Khuluza F; Department of Pharmacology & Pharmacognosy, School of Pharmacy, University of Nairobi, Nairobi, Kenya.
  • Chiumia FK; Department of Pharmacology & Pharmacognosy, School of Pharmacy, University of Nairobi, Nairobi, Kenya.
  • Jana CE; Department of Pharmaceutics and Pharmacy Practice, School of Pharmacy, University of Nairobi, Nairobi, Kenya.
  • Kalemeera F; Pharmacy Department, Kamuzu University of Health Sciences (KUHeS) (formerly College of Medicine), Blantyre, Malawi.
  • Hango E; Pharmacy Department, Kamuzu University of Health Sciences (KUHeS) (formerly College of Medicine), Blantyre, Malawi.
  • Fadare J; Pharmacy Department, Kamuzu University of Health Sciences (KUHeS) (formerly College of Medicine), Blantyre, Malawi.
  • Ogunleye OO; Division of Biochemistry, Biomedical Sciences Department, Kamuzu University of Health Sciences (KUHeS) (formerly College of Medicine), Blantyre, Malawi.
  • Ebruke BE; Department of Pharmacy Practice and Policy, Faculty of Health Sciences, University of Namibia, Windhoek, Namibia.
  • Meyer JC; Department of Pharmacy Practice and Policy, Faculty of Health Sciences, University of Namibia, Windhoek, Namibia.
  • Massele A; Department of Pharmacology and Therapeutics, Ekiti State University, Ado-Ekiti, Nigeria.
  • Malande OO; Department of Medicine, Ekiti State University Teaching Hospital, Ado-Ekiti, Nigeria.
  • Kibuule D; Department of Pharmacology, Therapeutics and Toxicology, Lagos State University College of Medicine, Ikeja, Lagos, Nigeria.
  • Kapona O; Department of Medicine, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria.
  • Zaranyika T; International Foundation Against Infectious Disease in Nigeria (IFAIN), Abuja, Nigeria.
  • Bwakura-Dangarembizi M; Department of Public Health Pharmacy and Management, Sefako Makgatho Health Sciences University, Pretoria, South Africa.
  • Kujinga T; Department of Clinical Pharmacology and Therapeutics, Hurbert Kairuki Memorial University, Dar Es Salaam, Tanzania.
  • Saleem Z; Department of Public Health Pharmacy and Management, Sefako Makgatho Health Sciences University, Pretoria, South Africa.
  • Kurdi A; Department of Child Health and Paediatrics, Egerton University, Nakuru, Kenya.
  • Shahwan M; East Africa Centre for Vaccines and Immunization (ECAVI), Kampala, Uganda.
  • Jairoun AA; Department of Pharmacology & Therapeutics, Busitema University, Mbale, Tororo, Uganda.
  • Wale J; Zambia National Public Health Institute, Lusaka, Zambia.
  • Brink AJ; Department Of Medicine, University of Zimbabwe College of Health Sciences, Harare, Zimbabwe.
Expert Opin Drug Saf ; 21(8): 1089-1111, 2022 Aug.
Article em En | MEDLINE | ID: mdl-35876080
ABSTRACT

INTRODUCTION:

Antimicrobial resistance (AMR) is a concern as this increases morbidity, mortality, and costs, with sub-Saharan Africa having the highest rates globally. Concerns with rising AMR have resulted in international, Pan-African, and country activities including the development of national action plans (NAPs). However, there is variable implementation across Africa with key challenges persisting. AREAS COVERED Consequently, there is an urgent need to document current NAP activities and challenges across sub-Saharan Africa to provide future guidance. This builds on a narrative review of the literature. EXPERT OPINION All surveyed sub-Saharan African countries have developed their NAPs; however, there is variable implementation. Countries including Botswana and Namibia are yet to officially launch their NAPs with Eswatini only recently launching its NAP. Cameroon is further ahead with its NAP than these countries; though there are concerns with implementation. South Africa appears to have made the greatest strides with implementing its NAP including regular monitoring of activities and instigation of antimicrobial stewardship programs. Key challenges remain across Africa. These include available personnel, expertise, capacity, and resources to undertake agreed NAP activities including active surveillance, lack of focal points to drive NAPs, and competing demands and priorities including among donors. These challenges are being addressed, with further co-ordinated efforts needed to reduce AMR.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Farmacorresistência Bacteriana / Antibacterianos Limite: Humans País/Região como assunto: Africa Idioma: En Revista: Expert Opin Drug Saf Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Farmacorresistência Bacteriana / Antibacterianos Limite: Humans País/Região como assunto: Africa Idioma: En Revista: Expert Opin Drug Saf Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido